All News about Corcept Therapeutics
![](https://www.chartmill.com/images/uploads/Affordable_Growth_500_264px_webp_add6a3aa59.webp)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.png?width=1200&height=800&fit=crop)
Unveiling 8 Analyst Insights On Corcept Therapeutics
July 30, 2024
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://ml.globenewswire.com/media/1f9d2274-4c2d-4740-8608-9c6039c1cbc1/small/corcept-logo-new-black-png.png)
![](https://ml.globenewswire.com/media/1f9d2274-4c2d-4740-8608-9c6039c1cbc1/small/corcept-logo-new-black-png.png)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.png?width=1200&height=800&fit=crop)
6 Analysts Have This To Say About Corcept Therapeutics
June 17, 2024
Via Benzinga
![](https://www.chartmill.com/images/uploads/Affordable_Growth_500_264px_webp_add6a3aa59.webp)
![](https://www.chartmill.com/images/uploads/Strong_Growth_500_264px_webp_8f1ee6ba5b.webp)
![](https://www.chartmill.com/images/uploads/Affordable_Growth_500_264px_webp_add6a3aa59.webp)
![](https://investorplace.com/wp-content/uploads/2022/10/biotechnology1600.png)
![](https://investorplace.com/wp-content/uploads/2022/06/biotechnologyepzm1600.png)
![](https://ml.globenewswire.com/media/1f9d2274-4c2d-4740-8608-9c6039c1cbc1/small/corcept-logo-new-black-png.png)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.jpeg?width=1200&height=800&fit=crop)
![](https://www.chartmill.com/images/uploads/Strong_Growth_500_264px_webp_8f1ee6ba5b.webp)
![](https://www.chartmill.com/images/uploads/Affordable_Growth_500_264px_webp_add6a3aa59.webp)
![](https://cdn.benzinga.com/files/images/story/2024/06/14/movers-image_24.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/options_image_2.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://ml.globenewswire.com/media/1f9d2274-4c2d-4740-8608-9c6039c1cbc1/small/corcept-logo-new-black-png.png)
![](https://cdn.benzinga.com/files/images/story/2024/05/28/Close-Up-Shot-Of-Nvidia-Brand-Logo-On-Vi.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/05/28/movers-image_23.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/05/28/Medical-Examination-And-Healthcare-Busin_0.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://ml.globenewswire.com/media/1f9d2274-4c2d-4740-8608-9c6039c1cbc1/small/corcept-logo-new-black-png.png)
![](https://www.chartmill.com/images/uploads/Affordable_Growth_500_264px_webp_add6a3aa59.webp)
![](https://cdn.benzinga.com/files/images/story/2023/options_image_0.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://ml.globenewswire.com/media/1f9d2274-4c2d-4740-8608-9c6039c1cbc1/small/corcept-logo-new-black-png.png)
![](https://ml.globenewswire.com/media/1f9d2274-4c2d-4740-8608-9c6039c1cbc1/small/corcept-logo-new-black-png.png)
Corcept Completes Enrollment in Phase 4 CATALYST Trial
April 29, 2024
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.